Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...

Lab tests play a key role in clinical decision-making. More than 4000 lab tests are available, and an estimated 70% of clinical decisions are based on their results. Correct interpretation is critical ...

Caplyta (lumateperone) is a brand-name capsule prescribed for schizophrenia and depressive episodes due to bipolar disorder. Caplyta has interactions with some other drugs. Examples include certain ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...